The future of cancer research

29 October 2026

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing, and Nomic Bio, a leader in high through-put proteomic profiling,… read more

24 September 2026

Announcement

Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration

Turbine and Daiichi Sankyo, a global healthcare company with an industry-leading antibody-drug conjugate (ADC) portfolio, today announced a strategic partnership to accelerate and de-risk ADC… read more